Did the new French pay-for-performance system modify benzodiazepine prescribing practices?

BMC Health Services Research

Volumn 14, Issue 1, 2014, Pages

  Rat, Cedric ^a,b   Penhouet, Gaëlle ^a   Gaultier, Aurelie ^c   Chaslerie, Anicet ^d   Pivette, Jacques ^d   Nguyen, Jean Michel ^b,c   Victorri Vigneau, Caroline ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b CNRS   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d Medical Department of the French Health Insurance System   (France)

Author keywords

Benzodiazepines; Drug prescriptions; Family practice; France; Guideline adherence; Pay for performance

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; CLINICAL PRACTICE; FEMALE; FRANCE; GENERAL PRACTICE; HUMAN; MALE; MIDDLE AGED; REIMBURSEMENT; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGED; BENZODIAZEPINES; FEMALE; FRANCE; GENERAL PRACTICE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; REIMBURSEMENT, INCENTIVE;

EID: 84904082250     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-301     Document Type: Article

References (45)

1. Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. Clay E, Falissard B, Moore N, Toumi M, Eur J Clin Pharmacol 2013 69 1 10
2. Etat des Lieux de la consommation des benzodiazepines en France, Rapport d'expertise. Agence Française de Securite Sanitaire des Produits de Sante, [ http://www.apima.org/img-bronner/Afssaps-rapport-benzodiazepines.pdf ]
3. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA, Arch Intern Med 2009 169 1952 1960
4. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Hogan DB, Maxwell CJ, Fung TS, Ebly EM, Canadian Study of Health and Aging, Can J Clin Pharmacol 2003 10 72 77 (Pubitemid 37028597)
5. Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey. Belleville G, Can J Psychiatry 2010 55 558 567
6. A systematic review of research examining benzodiazepine-related mortality. Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M, Pharmacoepidemiol Drug Saf 2009 18 93 103
7. Benzodiazepine use and risk of dementia: prospective population based study. BilliotideGage S, Begaud B, Bazin F, Verdoux H, Dartigues JF, Perès K, Kurth T, Pariente A, BMJ 2012 345 6231
8. Summary of product characteristics for benzodiazepines as anxiolytics or hypnotics. European Medicines Agency, [ http://www.ema.europa.eu/docs/en-GB/ document-library/Scientific-guideline/2009/09/WC500003774.pdf ]
9. National Collaborating Centre for Mental Health, Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care London 2004
10. Arrête du 22 septembre 2011 portant approbation de la convention nationale des medecins generalistes et specialistes. Republique Française, [ http://www.legifrance.gouv.fr/affichTexte.do?cidTexte= JORFTEXT000024803740 ]
11. Modalites d'arrêt des benzodiazepines et medicaments apparentes chez le patient âge Haute Autorite de Sante [ http://www.has-sante.fr/ portail/jcms/c-601509/modalites-d-arret-des-benzodiazepines-et-medicaments- apparentes-chez-le-patient-age?xtmc=benzodiazepines&xtcr=4 ]
12. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Mugunthan K, McGuire T, Glasziou P, Br J Gen Pract 2011 61 573 578
13. Pharmacological interventions for benzodiazepine mono-dependence management in outpatients settings. Denis C, Fatseas M, Lavie E, Auriacombe M, Cochrane Database Syst Rev 2006 3, CD005194
14. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. Liu GG, Christensen DB, J Am Pharm Assoc 2002 42 847 857
15. Hazardous benzodiazepine regimens in the elderly: effects of a half-life, dosage, and duration on risk of hip fracture. Wangs PS, Bohn RL, Glynn RJ, Mogun H, Avorn J, Am J Psychiatry 2001 158 892 898 (Pubitemid 32547618)
16. Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system. Bongue B, Laroche ML, Gutton S, Colvez A, Gueguen R, Moulin JJ, Merle L, Eur J Clin Pharmacol 2011 67 1291 1299
17. [Potentially inappropriate prescriptions for the elderly: a study of health insurance reimbursements in Southeastern France]. Jardin M, Bocquier A, Cortaredona S, Nauleau S, Millon C, Savard-Chambard S, Allaria-Lapierre V, Sciortino V, Bouvenot G, Verger P, Rev Epidemiol Sante Publique 2012 60 121 130
18. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Parr JM, Kavanagh DJ, Cahill L, Mitchell G, McD Young R, Addiction 2008 104 13 24
19. Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Lechevallier-Michel N, Gautier-Bertrand M, Alperovitch A, Berr C, Belmin J, Legrain S, Saint-Jean O, Tavernier B, Dartigues JF, Fourrier-Reglat A, 3C Study Group, Eur J Clin Pharmacol 2005 60 813 819
20. Institute for Statistics and Mathematics of WU (Wirtschaftsuniversität Wien). The comprehensive R archive network, [ http://cran.r-project.org ]
21. French Public Health Code. Article R. 1121-2. [ http://www.legifrance. gouv.fr ]
22. The effect of financial incentives on the quality of health care provided by primary care physicians. Scott A, Sivey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J, Young D, Cochrane Database Syst Rev 2011 9 D008451
23. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Flodgren G, Eccles MP, Shepperd S, Scott A, Parmelli E, Beyer FR, Cochrane Database Syst Rev 2011 7 D009255
24. Hypnotic prescription without face to face contact: a report from French family medicine. Rat C, Werner EL, Pivette J, Senand R, Nguyen JM, Eur J Gen Pract 2013 19 158 161
25. Potentially inappropriate medication use among Finnish non-institutionalized people aged ≥65 years: a register-based, cross-sectional, national study. Leikola S, Dimitrow M, Lyles A, Pitkälä K, Airaksinen M, Drugs Aging 2011 28 227 236
26. Inappropriate drug use in the elderly: a nationwide register-based study. Johnell K, Fastbom J, Rosen M, Leimanis A, Ann Pharmacother 2007 41 1243 1248 (Pubitemid 47122563)
27. Reimbursement restriction and moderate decrease in benzodiazepine use in general practice. Van Dijk L, Ann Fam Med 2012 10 42 49
28. Discontinuation of reimbursement of benzodiazepines in the Netherlands: does it make a difference? Kollen BJ, van der Veen WJ, Groenhof F, Donker GA, van der Meer K, BMC Fam Pract 2012 13 111
29. Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. Cook JM, Marshall R, Masci C, Coyne JC, J Gen Intern Med 2007 22 303 307 (Pubitemid 46941221)
30. Cognitive behavioral therapy in anxiety disorders: current state of the evidence. Otte C, Dialogues Clin Neurosci 2011 13 413 421
31. Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia. Anthierens S, Pasteels I, Habraken H, Steinberg P, Declercq T, Christiaens T, Can Fam Physician 2010 56 398 406
32. Financial crisis, austerity, and health in Europe. Karanikolos M, Mladovsky P, Cylus J, Thomson S, Basu S, Stuckler D, Mackenbach JP, McKee M, Lancet 2013 381 1323 1331
33. The mental health risks of economic crisis in Spain: evidence from primary care centres, 2006 and 2010. Gili M, Roca M, Basu S, McKee M, Stuckler D, Eur J Public Health 2013 23 103 108
34. Effects of the 2008 recession on health: a first look at European data. Stuckler D, Basu S, Suhrcke M, Coutts A, McKee M, Lancet 2011 378 124 125
35. Suicides associated with the 2008-10 economic recession in England: time trend analysis. Barr B, Taylor-Robinson D, Scott-Samuel A, McKee M, Stuckler D, BMJ 2012 345 5142
36. Increased suicidality amid economic crisis in Greece. Economou M, Madianos M, Theleritis C, Peppou LE, Stefanis CN, Lancet 2011 378 1459
37. Iatrogenic causes of falls in hospitalised elderly patients: a case-control study. Frels C, Williams P, Narayanan S, Gariballa SE, Postgrad Med J 2002 78 487 489 (Pubitemid 34948158)
38. New evidence on benzodiazepine use and falls: the time factor. Neutel CI, Hirdes JP, Maxwell CJ, Patten SB, Age Ageing 1996 25 273 278 (Pubitemid 26245275)
39. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell'Anziano. Passaro A, Volpato S, Romagnoni F, Manzoli N, Zuliani G, Fellin R, J Clin Epidemiol 2000 53 1222 1229 (Pubitemid 32007838)
40. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. Leipzig R, Cumming R, Tinetti M, J Am Geriatr Soc 1999 47 30 39 (Pubitemid 29044264)
41. Side effects of treatment with benzodiazepines. Uzun S, Kozumplik O, Jakovljevic M, Sedic B, Psychiatr Danub 2010 22 90 93
42. Potentially inappropriate medications in the elderly: a French consensus panel list. Laroche ML, Charmes JP, Merle L, Eur J Clin Pharmacol 2007 63 725 731 (Pubitemid 47052052)
43. Benzodiazepines: a summary of pharmacokinetic properties. Greenblatt DJ, Shader RI, Divoll M, Harmatz JS, Br J Clin Pharmacol 1981 11 Suppl 1 11S 16S (Pubitemid 11098008)
44. Mise à jour sur les considerations pharmacocinetiques, pharmacodynamiques et les interactions medicamenteuses dans le choix d'une benzodiazepine. Landry P, Gervais M, O'Connor KP, Ann Medico-Psychol 2008 166 585 594
45. Generalized anxiety disorder: diagnosis and treatment. Hoge EA, Ivkovic A, Fricchione GL, BMJ 2012 345 7500